Lineage Cell Therapeutics (LCTX) Non-Current Deffered Revenue (2010 - 2026)
Lineage Cell Therapeutics' Non-Current Deffered Revenue came in at $12.34 million for Q2 2026, down 3.2% from $12.75 million a year earlier and down 5.1% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends
At the end of FY2025, Lineage Cell Therapeutics' Non-Current Deffered Revenue was $12.38 million, down 14.2% from FY2024.
- Non-Current Deffered Revenue has declined in each of the last four years, with a four-year compound annual growth rate of -21.4% (FY2021 to FY2025).
- Going back by year, Non-Current Deffered Revenue was $14.43 million in FY2024 (-22.8%), $18.69 million in FY2023 (-32.6%), $27.73 million in FY2022 (-14.6%) and $32.45 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Non-Current Deffered Revenue since Q4 2019.
- Year-over-year, Non-Current Deffered Revenue has declined for 15 consecutive quarters, with an average decline of 18.5% over the last eight quarters.
- The year-over-year decline in Non-Current Deffered Revenue has ranged between 3.2% (Q2 2026) and 32.6% (Q4 2023) over the last five years.
- Business Quant data shows LCTX's Non-Current Deffered Revenue at $13 million (Q1 2026), $12.38 million (Q4 2025) and $12.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | - |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Lineage Cell Therapeutics | 247.85 Mn | 46.25 Mn | - | 12.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.34 Mn |
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 12.38 Mn |
| Sep 30, 2025 | 12.46 Mn |
| Jun 30, 2025 | 12.75 Mn |
| Mar 31, 2025 | 13.61 Mn |
| Dec 31, 2024 | 14.43 Mn |
| Sep 30, 2024 | 16.05 Mn |
| Jun 30, 2024 | 18.54 Mn |
| Mar 31, 2024 | 18.18 Mn |
| Dec 31, 2023 | 18.69 Mn |
| Sep 30, 2023 | 21.20 Mn |
| Jun 30, 2023 | 21.69 Mn |
| Mar 31, 2023 | 24.02 Mn |
| Dec 31, 2022 | 27.73 Mn |
| Sep 30, 2022 | 26.54 Mn |
| Jun 30, 2022 | 25.77 Mn |
| Mar 31, 2022 | 30.82 Mn |
| Dec 31, 2021 | 32.45 Mn |
| Dec 31, 2019 | 200,000.00 |
API Access
Lineage Cell Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();